Gozde Colak

2.5k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

Gozde Colak is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gozde Colak has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Genetics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gozde Colak's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Gozde Colak is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Multiple Myeloma Research and Treatments (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Gozde Colak collaborates with scholars based in United States, United Kingdom and Canada. Gozde Colak's co-authors include Gail V.W. Johnson, Janusz Tucholski, Soner Gundemir, Kapil Mehta, Mari T. Kaartinen, Richard L. Eckert, Maria Nurminskaya, Alexey M. Belkin, Yingming Zhao and Lunzhi Dai and has published in prestigious journals such as Journal of Clinical Oncology, Physiological Reviews and Blood.

In The Last Decade

Gozde Colak

24 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transglutaminase Regulation of Cell Function

2014 336 citations Gozde Colak, Gail V.W. Johnson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gozde Colak United States	13	508	466	167	148	146	30	1.2k
Roble Bedolla United States	21	523 1.0×	1.1k 2.4×	98 0.6×	234 1.6×	158 1.1×	36	1.8k
Peter Keng United States	22	232 0.5×	670 1.4×	77 0.5×	50 0.3×	58 0.4×	36	1.4k
Aurélie Bedel France	20	123 0.2×	888 1.9×	76 0.5×	64 0.4×	61 0.4×	41	1.3k
Yuan Tan China	22	164 0.3×	926 2.0×	124 0.7×	434 2.9×	87 0.6×	57	1.7k
Andrew D. Hollenbach United States	18	137 0.3×	937 2.0×	131 0.8×	109 0.7×	87 0.6×	30	1.2k
Liping Ma China	20	115 0.2×	432 0.9×	44 0.3×	128 0.9×	93 0.6×	87	1.1k
Greta Gandolfi Italy	19	164 0.3×	594 1.3×	67 0.4×	197 1.3×	110 0.8×	30	1.3k
Hidehiko Kikuchi Japan	20	155 0.3×	553 1.2×	56 0.3×	54 0.4×	100 0.7×	81	1.1k
Shouyue Zhang China	20	135 0.3×	736 1.6×	26 0.2×	245 1.7×	64 0.4×	34	1.2k
Ming He China	20	135 0.3×	528 1.1×	90 0.5×	98 0.7×	78 0.5×	58	973

Countries citing papers authored by Gozde Colak

Since Specialization

Citations

This map shows the geographic impact of Gozde Colak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gozde Colak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gozde Colak more than expected).

Fields of papers citing papers by Gozde Colak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gozde Colak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gozde Colak. The network helps show where Gozde Colak may publish in the future.

Co-authorship network of co-authors of Gozde Colak

This figure shows the co-authorship network connecting the top 25 collaborators of Gozde Colak. A scholar is included among the top collaborators of Gozde Colak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gozde Colak. Gozde Colak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baş, Murat, et al.. (2025). Intuitive Eating Intervention in Physically Active Adults: Effects on Anthropometry, Athletic Performance, Eating Attitudes, and Body Image. Nutrients. 17(17). 2824–2824.

Colak, Gozde, et al.. (2025). Does nutritional education affect the nutritional status, growth, and development of children with pectus excavatum?. Pediatric Surgery International. 41(1). 145–145.

Colak, Gozde, et al.. (2025). Myasthenia gravis and nutrition. Frontiers in Nutrition. 12. 1600508–1600508.

Stein, Eytan M., Amir T. Fathi, Wael A. Harb, et al.. (2024). Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies. Leukemia & lymphoma. 65(4). 503–510. 6 indexed citations

Gupta, Vikas, John Mascarenhas, Marina Kremyanskaya, et al.. (2023). Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis. Blood Advances. 7(18). 5421–5432. 4 indexed citations

Colak, Gozde, et al.. (2023). Ferulic Acid Treats Gastric Ulcer via Suppressing Oxidative Stress and Inflammation. Life. 13(2). 388–388. 27 indexed citations

Supko, Jeffrey G., Michael B. Maris, Ian W. Flinn, et al.. (2022). A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma. Cancer Research Communications. 2(8). 795–805. 23 indexed citations

Mascarenhas, John, Marina Kremyanskaya, Vikas Gupta, et al.. (2022). Pelabresib (CPI-0610) Combined with Ruxolitinib for JAK Inhibitor Treatment-Naïve Patients with Myelofibrosis: Durability of Response and Safety Beyond Week 24. Blood. 140(Supplement 1). 586–589. 4 indexed citations

Taplin, Mary‐Ellen, Arif Hussain, Satish Shah, et al.. (2019). ProSTAR: A phase Ib/II study of CPI-1205, a small molecule inhibitor of EZH2, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 37(7_suppl). TPS335–TPS335. 12 indexed citations

10.

Colak, Gozde, Lunzhi Dai, Minjia Tan, et al.. (2015). Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Molecular & Cellular Proteomics. 14(11). 3056–3071. 142 indexed citations

11.

Chen, Yue, Gozde Colak, & Yingming Zhao. (2013). SILAC-Based Quantification of Sirt1-Responsive Lysine Acetylome. Methods in molecular biology. 1077. 105–120. 11 indexed citations

12.

Colak, Gozde, Zhongyu Xie, Lunzhi Dai, et al.. (2013). Identification of Lysine Succinylation Substrates and the Succinylation Regulatory Enzyme CobB in Escherichia coli. Molecular & Cellular Proteomics. 12(12). 3509–3520. 220 indexed citations

13.

Gundemir, Soner, et al.. (2012). Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(1). 1–10. 31 indexed citations

14.

Thompson, Janice, Kiyotaka Hitomi, Erik N.T.P. Bakker, et al.. (2012). Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. American Journal of Physiology-Heart and Circulatory Physiology. 302(7). H1355–H1366. 23 indexed citations

15.

Gundemir, Soner, Gozde Colak, Janusz Tucholski, & Gail V.W. Johnson. (2011). Transglutaminase 2: A molecular Swiss army knife. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(2). 406–419. 200 indexed citations

16.

Colak, Gozde & Gail V.W. Johnson. (2011). Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia. Neurobiology of Disease. 45(3). 1042–1050. 34 indexed citations

17.

Colak, Gozde, Jeffrey W. Keillor, & Gail V.W. Johnson. (2011). Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation. PLoS ONE. 6(1). e16665–e16665. 33 indexed citations

18.

Colak, Gozde, Anthony J. Filiano, & Gail V.W. Johnson. (2011). The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse. Journal of Visualized Experiments. 21 indexed citations

19.

Colak, Gozde, Anthony J. Filiano, & Gail V.W. Johnson. (2011). The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse. Journal of Visualized Experiments. 4 indexed citations

20.

Filiano, Anthony J., Janusz Tucholski, Philip J. Dolan, Gozde Colak, & Gail V.W. Johnson. (2010). Transglutaminase 2 protects against ischemic stroke. Neurobiology of Disease. 39(3). 334–343. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact